AllianceBernstein’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-407,036
| Closed | -$17.2M | – | 3207 |
|
|
2023
Q2 | $17.2M | Sell |
407,036
-1,609,369
| -80% | -$65.1M | 0.01% | 916 |
|
|
2023
Q1 | $71.8M | Sell |
2,016,405
-97,051
| -5% | -$3.52M | 0.03% | 477 |
|
|
2022
Q4 | $77.5M | Sell |
2,113,456
-28,198
| -1% | -$1.11M | 0.03% | 451 |
|
|
2022
Q3 | $101M | Buy |
2,141,654
+77,401
| +4% | +$5M | 0.05% | 352 |
|
|
2022
Q2 | $148M | Buy |
2,064,253
+270,730
| +15% | +$19.8M | 0.07% | 252 |
|
|
2022
Q1 | $145M | Buy |
1,793,523
+449,899
| +33% | +$38.1M | 0.06% | 313 |
|
|
2021
Q4 | $138M | Buy |
1,343,624
+1,144,983
| +576% | +$110M | 0.05% | 356 |
|
|
2021
Q3 | $17.4M | Buy |
198,641
+223
| +0.1% | +$20.2K | 0.01% | 1001 |
|
|
2021
Q2 | $17.8M | Buy |
198,418
+20,561
| +12% | +$1.74M | 0.01% | 989 |
|
|
2021
Q1 | $13.5M | Buy |
177,857
+14,602
| +9% | +$1.1M | 0.01% | 1065 |
|
|
2020
Q4 | $11.1M | Buy |
163,255
+33,290
| +26% | +$2.08M | 0.01% | 1080 |
|
|
2020
Q3 | $6.91M | Sell |
129,965
-15,614
| -11% | -$930K | ﹤0.01% | 1179 |
|
|
2020
Q2 | $8.48M | Sell |
145,579
-83,780
| -37% | -$4.5M | 0.01% | 1069 |
|
|
2020
Q1 | $9.04M | Sell |
229,359
-17,870
| -7% | -$1.04M | 0.01% | 949 |
|
|
2019
Q4 | $14.7M | Buy |
247,229
+87,830
| +55% | +$4.72M | 0.01% | 921 |
|
|
2019
Q3 | $8.48M | Buy |
159,399
+475
| +0.3% | +$24.4K | 0.01% | 1119 |
|
|
2019
Q2 | $8.12M | Sell |
158,924
-35,540
| -18% | -$1.65M | 0.01% | 1142 |
|
|
2019
Q1 | $10.1M | Buy |
194,464
+40,780
| +27% | +$1.98M | 0.01% | 1057 |
|
|
2018
Q4 | $6.05M | Buy |
153,684
+71,050
| +86% | +$3.3M | ﹤0.01% | 1214 |
|
|
2018
Q3 | $4.26M | Buy |
82,634
+360
| +0.4% | +$17.6K | ﹤0.01% | 1398 |
|
|
2018
Q2 | $3.86M | Sell |
82,274
-2,523
| -3% | -$104K | ﹤0.01% | 1429 |
|
|
2018
Q1 | $3.01M | Buy |
84,797
+398
| +0.5% | +$15.6K | ﹤0.01% | 1536 |
|
|
2017
Q4 | $3.68M | Sell |
84,399
-22,400
| -21% | -$1.05M | ﹤0.01% | 1417 |
|
|
2017
Q3 | $5.59M | Sell |
106,799
-29,080
| -21% | -$1.62M | ﹤0.01% | 1165 |
|
|
2017
Q2 | $7.95M | Buy |
135,879
+38,549
| +40% | +$2M | 0.01% | 1001 |
|
|
2017
Q1 | $4.46M | Sell |
97,330
-21,740
| -18% | -$1.08M | ﹤0.01% | 1251 |
|
|
2016
Q4 | $6.26M | Buy |
119,070
+10,700
| +10% | +$518K | 0.01% | 1075 |
|
|
2016
Q3 | $4.83M | Buy |
108,370
+20,390
| +23% | +$884K | ﹤0.01% | 1141 |
|
|
2016
Q2 | $3.35M | Buy |
87,980
+51,820
| +143% | +$2.28M | ﹤0.01% | 1284 |
|
|
2016
Q1 | $1.49M | Buy |
36,160
+10,760
| +42% | +$443K | ﹤0.01% | 1844 |
|
|
2015
Q4 | $1.23M | Sell |
25,400
-1,530
| -6% | -$68.1K | ﹤0.01% | 2003 |
|
|
2015
Q3 | $1.08M | Buy |
26,930
+3,330
| +14% | +$145K | ﹤0.01% | 2117 |
|
|
2015
Q2 | $947K | Buy |
23,600
+11,900
| +102% | +$411K | ﹤0.01% | 2315 |
|
|
2015
Q1 | $383K | Buy |
11,700
+9,500
| +432% | +$262K | ﹤0.01% | 2589 |
|
|
2014
Q4 | $57K | Buy |
+2,200
| New | +$52.3K | ﹤0.01% | 3085 |
|
Other funds holding SYNH
IA
BTI
CFB
HNB
AllianceBernstein's SYNH Position: Q3 2023 in Review
AllianceBernstein sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 407,036 shares — an estimated $17.2M sold.
AllianceBernstein first reported a position in SYNH in Q4 2014 and held it in 35 quarters. The position peaked at $148M in Q2 2022. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.
- AllianceBernstein reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- AllianceBernstein sold 407,036 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $17.2M.
- AllianceBernstein first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 35 quarters.
- AllianceBernstein's Syneos Health, Inc. Class A Common Stock position peaked at $148M in Q2 2022.
- 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.
Based on AllianceBernstein's 13F filing for Q3 2023, filed 14 Nov 2023.